NLS Pharmaceutics AG (NLSP) Cash Flow Annual - Discounting Cash Flows
NLSP
NLS Pharmaceutics AG
NLSP (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
Report Filing: 2024-10-18 2024-05-15 2023-05-05 2022-03-24 2021-05-14 2019-12-31 2018-12-31 2017-12-31
Net Income/Starting Line -2.04 -12.17 -16.5 -11.95 -2.86 -5.45 -5.15 -6.66
Cash From Operating Activities -1.53 -9.68 -13.88 -14.94 -0.729 -0.19 -2.73 -5.43
Depreciation and Amortization 0.006 0.011 0.011 0.01 72.19 0 1.09 0
Deferred Income Tax 0 0 0.613 0 0 0 0 0
Stock Based Compensation 0 0.165 0.023 0 0 0 0 0
Other Non-Cash Items 0.101 0.06 0.365 0.167 -72.12 1.14 1.22 0.884
Changes in Working Capital 0.401 2.25 1.63 -3.17 2.06 4.12 0.102 0.34
Accounts Receivable 0 0 0 -0.022 -0.013 0.001 -0.041 0
Inventory 0 0 0 0 0 -0 0 -0
Accounts Payable 1.47 2.26 0.636 -2.27 1.5 1.38 0 0.35
Deferred Revenue 0.45 -0.009 0.991 -0.875 0.58 2.74 0.143 -0.01
Other Working Capital -1.52 0 0 0 0 0 0 0
Cash From Investing Activities 0 0 -3.51 -0.04 0.226 -0.217 0 0
Investments in Property Plant and Equipment -0 -0 0 -0.04 0 0 0 0
Payments for Acquisitions 0 0 0 0 0 0 0 0
Purchases of Securities 0 0 0 0 0 0 0 0
Sales and Maturities of Investments 0 0 0 0 0 0 0 0
Other Investing Activities 0 0 0 0 0 0 0 0
Cash From Financing Activities 1.19 1.63 17.4 20.34 0.504 0.407 0.558 6.73
Debt Repayment -0.195 1.63 0.826 -2.1 1.19 0.155 0 3.45
Common Stock Issued 1.38 0 9.22 14.55 0 0 0 3.28
Common Stock Repurchased 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0
Other Financing Activities 0.002 0 7.35 7.89 -0.687 0.253 0.558 3.28
Effect of Forex Changes on Cash 0 0 -0 -0 0 -0 -0.001 0.006
Net Change in Cash -8.4 -8.05 3.52 5.34 -0.127 0.214 -2.18 1.3
Cash at Beginning of Period 8.95 8.95 5.43 0.094 0.22 0.007 2.18 0.883
Cash at End of Period 0.553 0.898 8.95 5.43 0.094 0.22 0.007 2.18
Free Cash Flow -1.53 -9.68 -13.88 -14.98 -0.729 -0.19 -2.73 -5.43
Operating Cash Flow -1.53 -9.68 -13.88 -14.94 -0.729 -0.19 -2.73 -5.43
Capital Expenditure -0 -0 0 -0.04 0 0 0 0
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us